Investigation of anti-middle east respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, Fall 2012

Journal of Infectious Diseases

Volumn 209, Issue 2, 2014, Pages 243-246

  Aburizaiza, Asad S ^a   Mattes, Frank M ^b,d   Azhar, Esam I ^b   Hassan, Ahmed M ^b   Memish, Ziad A ^c   Muth, Doreen ^e   Meyer, Benjamin ^e   Lattwein, Erik ^f   Müller, Marcel A ^e   Drosten, Christian ^e  

^a Enviromental Science Department   (Saudi Arabia)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c MINISTRY OF HEALTH   (Saudi Arabia)

^d Sustainable Sanitation Ecosan Program   (Germany)

^e UNIVERSITY HOSPITAL BONN   (Germany)

^f Institute of Experimental Immunology   (Germany)

Author keywords

MERS Coronavirus; Population immunity; Serology

Indexed keywords

IMMUNOGLOBULIN M; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; CORONAVIRUS; CROSS REACTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOFLUORESCENCE TEST; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SAUDI ARABIA; SLAUGHTERHOUSE; VIRUS NEUTRALIZATION; WORKER;

EID: 84891503386     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit589     Document Type: Article

References (13)

1. Memish ZA, Zumla AI, Al-Hakeem RF, Al-Rabeeah AA, Stephens GM. Family cluster of middle east respiratory syndrome coronavirus infections. N Engl J Med 2013; 368:2487-94
2. Cauchemez S, Epperson S, Biggerstaff M, Swerdlow D, Finelli L, Ferguson NM. Using routine surveillance data to estimate the epidemic potential of emerging zoonoses: Application to the emergence of US swine origin influenza A H3N2v virus. PLoS Med 2013; 10:e1001399
3. Drosten C, Seilmaier M, Corman VM, et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 2013; 13:745-51
4. Reusken CB, Haagmans BL, Muller MA, et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: A comparative serological study. Lancet Infect Dis 2013; pii: S1473-3099(13)70164- 6
5. Chan KH, Chan JF, Tse H, et al. Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests. J Infect 2013; 67:130-40
6. Buchholz U, Muller MA, Nitsche A, et al. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveill 2013; 18. pii: 20406
7. de Groot RJ, Baker SC, Baric RS, et al. Middle east respiratory syndrome coronavirus (MERS-CoV); announcement of the coronavirus study group. J Virol 2013; 87:7790-2
8. Corman V, Muller M, Costabel U, et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill 2012; 17. pii: 20334
9. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367:1814-20
10. Herzog P, Drosten C, Muller MA. Plaque assay for human coronavirus NL63 using human colon carcinoma cells. Virol J 2008; 5:138
11. Al-Tawfiq JA, Memish ZA. The Hajj: Updated health hazards and current recommendations for 2012. Euro Surveill 2012; 17:20295
12. Benkouiten S, Charrel R, Belhouchat K, et al. Circulation of respiratory viruses among pilgrims during the 2012 Hajj pilgrimage. Clin Infect Dis 2013; 57:992-1000
13. Gautret P, Charrel R, Belhouchat K, et al. Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms. Clin Microbiol Infect 2013; 19:E315-7